A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2009
11/18/2009	CN101580539A Polypeptide for inducing CD4CD25 regulatory T cells and application
11/18/2009	CN101580525A Method for extracting salidroside, polysaccharose and tannin-type substances from rhodiola root crude drugs
11/18/2009	CN101580480A Method for preparing substance-glutamine for increasing immunoregulation of grice
11/18/2009	CN101579529A Oligonucleotide compositions and method for treating disease including inflammatory conditions
11/18/2009	CN101579458A Traditional Chinese medicine for treating infant influenza
11/18/2009	CN101579352A Application of polysaccharide component of longan pulp in pharmacy
11/18/2009	CN100561229C A cytocapacity test
11/18/2009	CN100560723C Recombinant human sCTLA4-Ig fusion protein gene and its medicinal composition
11/18/2009	CN100560570C Method of synthesizing 5-(4-chloro-phenyl)-N-hydroxy-1-(4-methoxy-phenyl)-N-methyl-1H-pyrazole-3-propionamide
11/18/2009	CN100560095C Compound preparation containing extractive of almond and extractive of ginkgo leaf
11/18/2009	CN100560090C Methods of acquiring total tanshinone and total phenolic acid
11/18/2009	CN100560084C Method and preparations having effect against allergic symptoms
11/18/2009	CN100560081C Method for extracting flavonoids from the waxberry core
11/18/2009	CN100560080C Composition containing nucleoside and its preparing method
11/18/2009	CN100559963C Feed without public nuisance
11/17/2009	USRE40987 for the treatment and prevention of AIDS
11/17/2009	US7619065 Cystine-knot fold protein
11/17/2009	US7619063 Chimeric protein including a protein from parainfluenza virus and a protein from respiratory syncytial virus, capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV); vaccines
11/17/2009	US7619001 Utilization of dialkylfumarates
11/17/2009	US7618994 Such as (+/-)-[9-(4-chlorobenzyl)-6-fluoro-8-methanesulfonyl-2, 3,4,9-tetrahydro-1H-carbazol-1-yl]acetic acid; prostaglandin receptor antagonists; antihistamines; nasal decongestion, rhinitis
11/17/2009	US7618935 Chaperonin 10 immunosuppression
11/17/2009	US7618791 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
11/17/2009	US7618649 For therapy of nasal and non-nasal symptoms of perennial and seasonal allergic rhinitis
11/17/2009	US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009	US7618628 CD16A binding proteins and use for the treatment of immune disorders
11/17/2009	US7618621 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
11/17/2009	CA2588495C The utility of uridine nucleosides in the treatment of cachexia
11/17/2009	CA2510949C Polymorph of ritonavir
11/17/2009	CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009	CA2396062C Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity
11/17/2009	CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/17/2009	CA2376850C Topical formulations comprising skin penetration agents and the use thereof
11/17/2009	CA2339090C Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
11/17/2009	CA2259583C Azolo triazines and pyrimidines
11/17/2009	CA2249181C Scf analog compositions and methods
11/17/2009	CA2230949C Synthetic peptides that inhibit il-6 activity
11/12/2009	WO2009137605A2 AFFINITY MATURED CRIg VARIANTS
11/12/2009	WO2009137596A1 Substituted amides, method of making, and use as btk inhibitors
11/12/2009	WO2009136805A1 Immunostimulating agent and a method for the production thereof
11/12/2009	WO2009136780A1 Anti-allergic vaccine for treating recurrent inflammation of the respiratory tract
11/12/2009	WO2009136625A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
11/12/2009	WO2009136370A1 Parenteral supplement with traceelemξntsfor treatment of i. a. sirs, burns selenium-defenciencies
11/12/2009	WO2009136144A1 Purine derivatives suitable for the treatment of cancer, autoimmune and inflammatory diseases
11/12/2009	WO2009135880A1 Cistus extract containing enriched secondary plant ingredients
11/12/2009	WO2009135858A1 Sialic acid to support the immune system in the elderly
11/12/2009	WO2009135615A2 Means for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory t-cells
11/12/2009	WO2009135352A1 A plum tree extract, a method for preparing the plum tree extract and use thereof
11/12/2009	WO2009114461A3 Angiotensin (1-7) dosage forms and uses thereof
11/12/2009	WO2009099672A3 Breaking immunological tolerance with a genetically encoded unnatural amino acid
11/12/2009	WO2009043519A3 Use of band 3 protein and pacap-27 as a therapeutic agent
11/12/2009	WO2009043454A3 Use of pacap-27 as a therapeutic agent
11/12/2009	WO2009039976A3 Use of a peptide as a therapeutic agent
11/12/2009	WO2009033767A3 Use of a peptide as a therapeutic agent
11/12/2009	WO2009033757A3 Use of mage-3 antigen (271-279) as a therapeutic agent
11/12/2009	WO2009033756A3 Use of oxyntomodulin alone or in combination with melanotropin potentiating factor as a therapeutic agent
11/12/2009	WO2009033750A3 Use of phm-27 alone or in combination with leu-enkephalin as a therapeutic agent
11/12/2009	WO2009033711A3 Use of glp-1 as a therapeutic agent
11/12/2009	WO2009008719A3 Treatment and prevention of inflammatory diseases and autoimmune diseases
11/12/2009	US20090281187 Anti-allergic agent
11/12/2009	US20090281180 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester
11/12/2009	US20090281170 Polynucleotide therapy
11/12/2009	US20090281164 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/12/2009	US20090281155 Dimeric Small Molecule Potentiators of Apoptosis
11/12/2009	US20090281128 Caspase inhibitors and uses thereof
11/12/2009	US20090281125 Heterocyclic Compounds Useful in Treating Diseases and Conditions
11/12/2009	US20090281123 Novel thiazolo (4,5-d) pyrimidine compounds novel compounds
11/12/2009	US20090281092 Polo-like kinase inhibitors
11/12/2009	US20090281087 Compounds II
11/12/2009	US20090281081 Chemokine receptor antagonists and methods of use therefor
11/12/2009	US20090281075 Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
11/12/2009	US20090280200 Herbal extracts which induce immune cells to produce interferon and activate toll-like receptors
11/12/2009	US20090280146 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
11/12/2009	US20090280143 Genetic adjuvants for immunotherapy
11/12/2009	US20090280138 Peptide
11/12/2009	US20090280137 Methods, Compositions, and Sequences of ZP-Binding Peptides for Immunocontraception of Dogs and Other Animals
11/12/2009	US20090280136 Immunization of fish with plant-expressed recombinant proteins
11/12/2009	US20090280131 IL-17 Antagonistic Antibodies
11/12/2009	US20090280129 High concentration antibody and protein formulations
11/12/2009	US20090280117 Methods for the treatment or prevention of immune disorders using anti-cd40 antibodies
11/12/2009	US20090280105 Novel Fungal Enzymes
11/12/2009	US20090280092 G-Protein Coupled Receptor 83 As a Molecular Switch for the Induction of Regulatory (immunosuppressive) T-cells
11/12/2009	US20090280087 Interferon AlPha And C-Phycocyanin For The Treatment Of Autoimmune Diseases, Allergy And Cancer
11/12/2009	US20090280085 Long Acting Human Interferon Analogs
11/12/2009	US20090280082 Methods for treating autoimmune disorders
11/12/2009	US20090280081 JAK/STAT pathway inhibitors and uses thereof
11/12/2009	DE102008023820A1 Mittel zur Behandlung und/oder Prophylaxe einer Autoimmunerkrankung und zur Bildung von Regulatorischen T-Zellen Agents for the treatment and / or prophylaxis of an autoimmune disease and the formation of regulatory T-cells
11/12/2009	CA2723761A1 Agent for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory t cells
11/12/2009	CA2723564A1 Sialic acid to support the immune system in the elderly
11/12/2009	CA2723484A1 Compositions obtained from chlorella extract having immunomodulating properties
11/12/2009	CA2723237A1 Substituted amides, method of making, and use as btk inhibitors
11/12/2009	CA2721815A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
11/12/2009	CA2721713A1 Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof
11/12/2009	CA2720685A1 Affinity matured crig variants
11/11/2009	EP2116263A1 Reversibly light-switchable drug-conjugates
11/11/2009	EP2116257A2 Parenteral vaccine formulations and uses thereof
11/11/2009	EP2116256A1 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same
11/11/2009	EP2116228A1 Novel cyclosporin analog microemulsion preconcentrates
11/11/2009	EP2116140A1 Sialic acid to support the immune system in the elderly
11/11/2009	EP2115129A2 Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr)
11/11/2009	EP2115006A2 Humanized antibodies against cxcr3

1 ... 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 ... 1172